A COMPARISON OF SAMPLE-SIZE METHODS FOR THE LOGRANK STATISTIC

被引:64
作者
LAKATOS, E [1 ]
LAN, KKG [1 ]
机构
[1] GEORGE WASHINGTON UNIV,DEPT STAT COMP & INFORMAT SYST,WASHINGTON,DC 20052
关键词
D O I
10.1002/sim.4780110205
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Several methods are available for sample size calculation for clinical trials when survival curves are to be compared using the logrank statistic. We discuss advantages and disadvantages of some of these methods, and present simulation results under exponential, proportional hazards and non-proportional hazard situations.
引用
收藏
页码:179 / 191
页数:13
相关论文
共 22 条
[1]  
Bernstein D., 1978, Journal of Statistical Computation and Simulation, V8, P65, DOI 10.1080/00949657808810249
[2]  
Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204
[3]   PLANNING SIZE AND DURATION OF A CLINICAL TRIAL STUDYING TIME TO SOME CRITICAL EVENT [J].
GEORGE, SL ;
DESU, MM .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2) :15-24
[4]  
Gill R. D., 1980, MATH CTR TRACTS, V124
[5]   SAMPLE SIZES FOR MEDICAL TRIALS WITH SPECIAL REFERENCE TO LONG-TERM THERAPY [J].
HALPERIN, M ;
ROGOT, E ;
GURIAN, J ;
EDERER, F .
JOURNAL OF CHRONIC DISEASES, 1968, 21 (01) :13-&
[6]   DESIGNING CLINICAL-TRIALS WITH ARBITRARY SPECIFICATION OF SURVIVAL FUNCTIONS AND FOR THE LOG RANK OR GENERALIZED WILCOXON TEST [J].
HALPERN, J ;
BROWN, BW .
CONTROLLED CLINICAL TRIALS, 1987, 8 (03) :177-189
[7]  
HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.1093/biomet/69.3.553
[8]  
KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI
[9]   INTRODUCTION TO SAMPLE-SIZE DETERMINATION AND POWER ANALYSIS FOR CLINICAL-TRIALS [J].
LACHIN, JM .
CONTROLLED CLINICAL TRIALS, 1981, 2 (02) :93-113
[10]   EVALUATION OF SAMPLE-SIZE AND POWER FOR ANALYSES OF SURVIVAL WITH ALLOWANCE FOR NONUNIFORM PATIENT ENTRY, LOSSES TO FOLLOW-UP, NONCOMPLIANCE, AND STRATIFICATION [J].
LACHIN, JM ;
FOULKES, MA .
BIOMETRICS, 1986, 42 (03) :507-519